Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nuvectis Pharma, Inc.

8.05
-0.0600-0.74%
Post-market: 8.050.00000.00%16:04 EDT
Volume:103.55K
Turnover:834.84K
Market Cap:190.26M
PE:-7.17
High:8.33
Open:8.11
Low:7.91
Close:8.11
Loading ...
Feb 06, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 01, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 31, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Nov 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 12, 2023

Major Issues Report

Form 8-K - Current report
Aug 17, 2023

Major Issues Report

Form 8-K - Current report
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2023

Major Issues Report

Form 8-K - Current report
Aug 09, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 03, 2023

Major Issues Report

Form 8-K - Current report
Jun 17, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Major Issues Report

Form 8-K - Current report
May 10, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2023

Major Issues Report

8-K - Current report
Apr 03, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 27, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 27, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 08, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]